Picture of 3-D Matrix logo

7777 3-D Matrix Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-14.4%
3m-13.77%
6m-37.17%
1yr-49.39%
Volume Change (%)
10d/3m-59.25%
Price vs... (%)
52w High-44.44%
50d MA-7.6%
200d MA-20.2%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-57.62%
Return on Equity-131.43%
Operating Margin-71.04%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Apr 202430th Apr 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of 3-D Matrix EPS forecast chart

Profile Summary

3-D Matrix, Ltd. is a company engaged in the research, development, manufacture and sale of medical products. The Company has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.

Directors

Last Annual
April 30th, 2023
Last Interim
January 31st, 2024
Incorporated
May 19th, 2004
Public Since
October 24th, 2011
No. of Shareholders
25,885
No. of Employees
108
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
79,350,463
Blurred out image of a map
Address
7F, CHIYODA-KU, 102-0083
Web
https://www.3d-matrix.co.jp/
Phone
+81 335113440
Auditors
Grant Thornton Taiyo LLC

7777 Share Price Performance

Upcoming Events for 7777

Dividend For 7777.T - 0.0000 JPY

Full Year 2024 3-D Matrix Ltd Earnings Release

Similar to 7777

Picture of AnGes logo

AnGes

jp flag iconTokyo Stock Exchange

Picture of BrightPath Biotherapeutics Co logo

BrightPath Biotherapeutics Co

jp flag iconTokyo Stock Exchange

Picture of Carna Biosciences logo

Carna Biosciences

jp flag iconTokyo Stock Exchange

Picture of Chiome Bioscience logo

Chiome Bioscience

jp flag iconTokyo Stock Exchange

Picture of Cyfuse Biomedical KK logo

Cyfuse Biomedical KK

jp flag iconTokyo Stock Exchange

FAQ

0